Research Article

Evaluation of Helicobacter pylori Infection with Endoscopic, Pathological, and Laboratory Findings

Volume: 13 Number: 2 June 30, 2022
EN TR

Evaluation of Helicobacter pylori Infection with Endoscopic, Pathological, and Laboratory Findings

Abstract

Aim: Helicobacter pylori, the most common bacterial infestation in the gastrointestinal tract. It is known to role in the development of intestinal metaplasia, dysplasia, gastric cancer, and atrophic gastritis. H. pylori infection has been thought to be related with many diseases such as iron deficiency, vitamin b deficiency…In our study, we aimed to evaluate the patients who underwent endoscopic examination in terms of endoscopic, pathological and laboratory (Hemogram and iron values) findings. Material and Methods: Between October 2020 and July 2021, 322 patients who were requested endoscopic examination and laboratory examination due to gastrointestinal system complaints were included in the study. Results: In our study; 152 H. pylori negative cases and 170 Helicobacter pylori positive cases were detected. Helicobacter pylori negative (HP-) group, the number of men was 50 and the number of women was 102. In the HP+ group, the number of men was 61 and the number of women was 109 (P=0.6387). The mean age in the (HP-) group was 51.48 ± 1.260. The mean age in the HP+ group was 48.29 ± 1.215 (P=0.0700). HGB value in the HP- group was 13.66 ± 0.1249, and in the HP+ group, it was found 13.95 ± 0.1359 (P=0.1194). The mean MCV value was found to be 85.74 ± 0.4877 in the HP- group, and 85.69 ± 0.5860 (P=0.9505) in the HP+ group. The mean Ferritin value in the HP- group was 38.71 ± 2.979, and 44.38 ± 3.195 (P=0.1983) in the HP+ group. In addition, 31 cases with Pangastritis in the HP- group and 54 cases in the HP+ group were detected (p=0.0208). Conclusion: In our study; the endoscopic, laboratory and pathological findings of HP infection were examined, no significant relationship was found between age, gender, HGB, MCV and Ferritin values with HP infection. There is no negative correlation with Antral gastritis and Atrophic gastritis in gastritis cases, a significant correlation was found between pangastritis and HP (p=0.0208)

Keywords

Project Number

yok

References

  1. 1. Graham DY, Malaty HM, Evans DG, Evans DJ Jr., Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100: 1495-501.
  2. 2. Lehours P, Yilmaz O. Epidemiology Helicobacter pylori infection. Helicobacter 2007; 12 : 1-3.
  3. 3. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 13115.
  4. 4. Schirer WH, Schoengold RJ, Baker JT, et al. Development of FlexSure HP-an immunochromatographic method to detect antibodies against Helicobacter pylori. Clin Chem 1998; 44: 293-8.
  5. 5. Kikuchi S, Wada O, Nakajima T, et al. Serum antiHelicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995; 75: 2789-93.
  6. 6. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992; 33: 16-20.
  7. 7. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterology Clinics of North America 2000; 29: 559-79.
  8. 8. Coyne D. Iron indices: what do they really mean? Kidney Int Suppl 2006: S4-8.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

June 30, 2022

Submission Date

February 2, 2022

Acceptance Date

May 26, 2022

Published in Issue

Year 2022 Volume: 13 Number: 2

APA
Avcı, M. A., Fidan, M. N., & Kaya, İ. O. (2022). Evaluation of Helicobacter pylori Infection with Endoscopic, Pathological, and Laboratory Findings. Turkish Journal of Clinics and Laboratory, 13(2), 202-206. https://doi.org/10.18663/tjcl.1067301
AMA
1.Avcı MA, Fidan MN, Kaya İO. Evaluation of Helicobacter pylori Infection with Endoscopic, Pathological, and Laboratory Findings. TJCL. 2022;13(2):202-206. doi:10.18663/tjcl.1067301
Chicago
Avcı, Mehmet Alperen, Merve Nergis Fidan, and İsmail Oskay Kaya. 2022. “Evaluation of Helicobacter Pylori Infection With Endoscopic, Pathological, and Laboratory Findings”. Turkish Journal of Clinics and Laboratory 13 (2): 202-6. https://doi.org/10.18663/tjcl.1067301.
EndNote
Avcı MA, Fidan MN, Kaya İO (June 1, 2022) Evaluation of Helicobacter pylori Infection with Endoscopic, Pathological, and Laboratory Findings. Turkish Journal of Clinics and Laboratory 13 2 202–206.
IEEE
[1]M. A. Avcı, M. N. Fidan, and İ. O. Kaya, “Evaluation of Helicobacter pylori Infection with Endoscopic, Pathological, and Laboratory Findings”, TJCL, vol. 13, no. 2, pp. 202–206, June 2022, doi: 10.18663/tjcl.1067301.
ISNAD
Avcı, Mehmet Alperen - Fidan, Merve Nergis - Kaya, İsmail Oskay. “Evaluation of Helicobacter Pylori Infection With Endoscopic, Pathological, and Laboratory Findings”. Turkish Journal of Clinics and Laboratory 13/2 (June 1, 2022): 202-206. https://doi.org/10.18663/tjcl.1067301.
JAMA
1.Avcı MA, Fidan MN, Kaya İO. Evaluation of Helicobacter pylori Infection with Endoscopic, Pathological, and Laboratory Findings. TJCL. 2022;13:202–206.
MLA
Avcı, Mehmet Alperen, et al. “Evaluation of Helicobacter Pylori Infection With Endoscopic, Pathological, and Laboratory Findings”. Turkish Journal of Clinics and Laboratory, vol. 13, no. 2, June 2022, pp. 202-6, doi:10.18663/tjcl.1067301.
Vancouver
1.Mehmet Alperen Avcı, Merve Nergis Fidan, İsmail Oskay Kaya. Evaluation of Helicobacter pylori Infection with Endoscopic, Pathological, and Laboratory Findings. TJCL. 2022 Jun. 1;13(2):202-6. doi:10.18663/tjcl.1067301

e-ISSN: 2149-8296

Publication Model: Continuous Publication

Peer Review Model: Double-Blind Peer Review

Publication Language: Turkish and English

Access Model: Open Access

DOI Prefix: (Crossref DOI numaranız)

Publisher: DNT Ortadoğu Publishing Inc.

Journal Abbreviation: Turk J Clin Lab

Indexed in J-Gate

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.